Inflammatory Cytokine Quantification in Infants

Completed

Conditions studied: Sepsis, Congenital Diaphragmatic Hernia, Neonatal Cardiopulmonary Failure

In brief

This study proposes to quantify inflammatory cytokine profiles in three neonatal disease states, namely, neonatal sepsis, infants with a congenital diaphragmatic hernia defect, and infants suffering cardiopulmonary failure significant enough to require heart/lung bypass treatment with extracorporeal membrane oxygenation (ECMO).

Key facts

Study ID

NCT01155830

Run by

University of Utah

People needed

21

Starts

2010-06-01

Expected to finish

2013-06-01

Last updated by the study team

2015-05-04

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Gestational age ≥ 34 weeks,
• Indwelling vascular catheter available for blood draws,
• Documented culture positive sepsis on vasopressors , and/or
• Congenital diaphragmatic hernia (CDH), and/or
• ECMO therapy

You may not qualify if…

• Other major congenital anomalies
• Lack of parental consent

Where it is running

• University of Utah — Salt Lake City, Utah, United States
• Primary Children's Medical Center — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.